PHARMA NORD ApS — Credit Rating and Financial Key Figures

PHARMA NORD ApS (CVR number: 67303016) is a company from HADERSLEV. The company reported a net sales of 486.7 mDKK in 2024, demonstrating a growth of 8.8 % compared to the previous year. The operating profit percentage was at 7.3 % (EBIT: 35.3 mDKK), while net earnings were 32.3 mDKK. The profitability of the company measured by Return on Assets (ROA) was 11.8 %, which can be considered good but Return on Equity (ROE) was 21.2 %, which can be considered excellent. The equity ratio, a key indicator for solidity, stood at 35.4 %, a level that can be considered to be low. This means a higher proportion of debt in its capital structure, indicating a greater reliance on borrowed funds. PHARMA NORD ApS's liquidity measured by quick ratio was 0.5 which is at a very low level. Thus, the company is in an unstable financial position, with its liquid assets significantly undermatching its current liabilities. This severe liquidity deficiency may lead to financial distress and threaten the company's operational continuity.